Adverse effects in maintenance therapy.
Adverse effects in maintenance therapy with neuroleptic drugs and lithium salts were reviewed with special emphasis on tardive dyskinesia. The possible teratogenicity of neuroleptics and lithium salts was discussed and the chromosomal abnormalities seen in patients treated with lithium salts described.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001847:Bone Diseases / Q000139:chemically induced; D001927:Brain Diseases / Q000139:chemically induced; D001943:Breast Neoplasms / Q000139:chemically induced; D002908:Chronic Disease; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005132:Eye Manifestations; D006801:Humans; D008094:Lithium / Q000009:adverse effects*; D001523:Mental Disorders / Q000188:drug therapy*; D009153:Mutagens; D012880:Skin Pigmentation / Q000187:drug effects; D013723:Teratogens
D014150:Antipsychotic Agents; D009153:Mutagens; D013723:Teratogens; D008094:Lithium